Obstetrics-gynecology

Has COVID-19 set back Canada’s HPV eradication targets?
Health Canada examines safety of inflammatory bowel disease drug mesalazine in pregnancy

Safety review could not confirm a link between the use of mesalazine (5-ASA) during pregnancy and birth defects in babies.
Fibristal voluntarily withdrawn in Canada due to risk of serious liver injury

Allergan withdraws and recalls uterine fibroid drug ulipristal acetate in Canada due to rare cases of severe liver injury requiring liver transplantation
Genetic mutations may be linked to infertility, early menopause

Gene in fruit flies, worms, zebrafish, mice and people may help explain some fertility issues
Researchers find cannabis use in pregnancy linked to greater risk of autism
How to manage Lyme disease and tick bites during pregnancy

SOGC statement provides guidance on caring for pregnant women who may have contracted Lyme disease through a blacklegged tick bite
Depressive symptoms with oral contraceptives

Adolescents, but not adult women, appear to be at increased risk for depressive symptoms when taking OCPs
Breastfeeding significantly decreases risk of invasive ovarian cancer

Largest study of breastfeeding and ovarian cancer risk to date provides evidence that breastfeeding reduces ovarian cancer risk, including high-grade serous subtype

U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later